Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, will present four abstracts at the 2025 American Society for Radiation Oncology Annual ...
SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, will present two oral abstracts at the 2024 American ...
• Teleflex (TFX) to host Barrigel™ Educational Symposium featuring a physician panel discussion on the Science of Personalized Spacing with Barrigel™ rectal spacer WAYNE, Pa., Sept. 26, 2024 (GLOBE ...
The MarketWatch News Department was not involved in the creation of this content. Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results